Document Detail


Costs and added value of haemodialysis and peritoneal dialysis outsourcing agreements.
MedLine Citation:
PMID:  22130280     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
BACKGROUND: Despite the discrepancy in results from Spanish studies on the costs of dialysis, it is assumed that peritoneal dialysis (PD) is more efficient than haemodialysis (HD).
OBJECTIVES: To analyse the costs and added value of HD and PD outsourcing agreements in Galicia, the medical transport for HD and the relationship between the cost of the agreement and the cost of consumables used in continuous ambulatory peritoneal dialysis (CAPD) with bicarbonate.
METHODS: The cost of the outsourcing agreements and the staff was obtained from official publications. The cost of PD and medical transport were calculated using health service data for one month and extrapolating it to one year. The cost of CAPD consumables was provided by the suppliers. The added value was calculated from the investments generated for each agreement treating 40 patients.
RESULTS: Expressed as patient/year, the mean costs for treatment were €21595 and €25664 in HD and PD, respectively. Medical transport varied between €3323 and €6338, while those of the CAPD agreement and consumables were €19268 and €12057, respectively. The added value was greater with the HD agreement, especially considering the jobs created.
CONCLUSIONS: One cannot generalise that the cost of PD, which is significantly influenced by prescriptions, is lower than that of HD. It would be appropriate to review the additional cost to consumables in the CAPD agreement. The added value generated by dialysis agreements should be considered in future studies and in health planning. More controlled studies are needed to better understand this issue.
Authors:
J M Lamas Barreiro; M Alonso Suárez; J A Saavedra Alonso; A Gándara Martínez
Publication Detail:
Type:  Comparative Study; Journal Article    
Journal Detail:
Title:  Nefrología : publicación oficial de la Sociedad Española Nefrologia     Volume:  31     ISSN:  1989-2284     ISO Abbreviation:  Nefrologia     Publication Date:  2011 Nov 
Date Detail:
Created Date:  2011-12-01     Completed Date:  2012-04-24     Revised Date:  2012-05-08    
Medline Journal Info:
Nlm Unique ID:  8301215     Medline TA:  Nefrologia     Country:  Spain    
Other Details:
Languages:  eng; spa     Pagination:  656-63     Citation Subset:  IM    
Affiliation:
Nephrology Department, University Hospital Complex of Vigo, Alto de Puxeiros s/n, Vigo, Pontevedra, Spain. jose.maria.lamas.barreiro@sergas.es
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Bicarbonates / economics
Cost-Benefit Analysis
Costs and Cost Analysis
Dialysis Solutions / economics
Disposable Equipment / economics
Financing, Government / statistics & numerical data
Health Personnel / economics
Humans
Kidney Failure, Chronic / economics,  therapy
National Health Programs / economics
Outsourced Services / economics*
Peritoneal Dialysis / economics*,  instrumentation
Peritoneal Dialysis, Continuous Ambulatory / economics
Reimbursement Mechanisms
Renal Dialysis / economics*,  instrumentation
Social Security / economics
Spain
Transportation of Patients / economics
Chemical
Reg. No./Substance:
0/Bicarbonates; 0/Dialysis Solutions
Comments/Corrections
Comment In:
Nefrologia. 2012;32(2):248-9; author reply 249-50   [PMID:  22466268 ]
Nefrologia. 2012;32(2):247-8; author reply 249-50   [PMID:  22466267 ]

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  The role of peritoneal dialysis in the treatment of ascites.
Next Document:  Appendix to Dialysis Centre Guidelines: Recommendations for the Relationship Between Outpatient Haem...